anonymous
Guest
anonymous
Guest
The sales are so low that the FDA does not care about off-label. They have bigger fish to fry.
This guy nose what he’s talking about.Many of us have expected the downfall of the nose for well over a year now and it hasn't happened. Something that popped up on my LinkedIn feed today seems to indicate that they are currently in the middle of a launch meeting. I would assume that is the CR indication. Wonder what that's going to do. That stock might be a good buy for a short-term gain.
Who Nose?Who is VP of sales at the nose?